September 20, 2018 / by Health Plan / Alerts, Pharmacy Announcements
Date: September 20, 2018 To: Primary Care Providers, Specialists, Clinics, Pharmacies and Hospitals From: Health Plan of San Joaquin Pharmacy Department Subject: NEW – Opioid 7-Day Supply Limit for Initial Fill Business: Medi-Cal To reduce the potential for chronic opioid use or misuse, Health Plan of San Joaquin is implementing a safety limit on initial […]
Read more
Reminder – Physician Certification Statement (PCS) Form – Update
October 31, 2018 / by Health Plan / Alerts, Pharmacy Announcements
Date: October 30, 2018 To: Health Plan of San Joaquin (HPSJ) Practitioners and Providers From: HPSJ [Medical Management Department] Subject: Reminder – Physician Certification Statement (PCS) Form Business: Medi-Cal Update As we continue to seek ways to streamline processes, Health Plan of San Joaquin has simplified prior authorization requirements for transportation for your busy office. […]
Read more
New Forms Update: 2018-2019 Palivizumab (Synagis)
October 25, 2018 / by Health Plan / Alerts, Pharmacy Announcements
Date: October 25, 2018 To: Health Plan of San Joaquin (HPSJ) Providers and Practitioners From: HPSJ [Medical Management Department] Subject: New Forms Update: 2018-2019 Palivizumab (Synagis) Business: Medi-Cal The Center of Disease Control and Prevention (CDC) reports that Respiratory syncytial virus (RSV) is known as one of the most common illnesses among infants and children. […]
Read more
2018 Immunization Updates: Flu, Tdap, HepB, Zoster, MMR, Adult Vaccines
September 28, 2018 / by Health Plan / Pharmacy Announcements
Each year, the California Medi-Cal Drug Use Review (DUR) program issues an annual summary of updates on immunization guidelines, products, and/or research in collaboration with the California Department of Public Health (CDPH) Immunization Branch. For reference, the recommended immunization schedules for 2018 in the United States can be accessed on the Centers for Disease Control […]
Read more
Alert: Mandatory Use of CURES 2.0 Begins October 2, 2018
September 28, 2018 / by Health Plan / Pharmacy Announcements
Dentist Physician Naturopathic Doctor Optometrist Osteopathic Doctor Physician Assistant Podiatrist Registered Certified Nurse Midwife (Furnishing) Registered Nurse Practitioner (Furnishing) These health care providers are required to consult the CURES 2.0 database to review a patient’s controlled substance history before prescribing a Schedule II – IV controlled substance to the patient for the first time and […]
Read more
NEW – Opioid 7-Day Supply Limit for Initial Fill
September 20, 2018 / by Health Plan / Alerts, Pharmacy Announcements
Date: September 20, 2018 To: Primary Care Providers, Specialists, Clinics, Pharmacies and Hospitals From: Health Plan of San Joaquin Pharmacy Department Subject: NEW – Opioid 7-Day Supply Limit for Initial Fill Business: Medi-Cal To reduce the potential for chronic opioid use or misuse, Health Plan of San Joaquin is implementing a safety limit on initial […]
Read more
Montelukast Recall
August 31, 2018 / by Health Plan / Alerts, Pharmacy Announcements
Date: August 31, 2018 To: Health Plan of San Joaquin (HPSJ) Pharmacies and PCPs From: HPSJ Pharmacy Department Subject: Montelukast Recall Business: Medi-Cal Montelukast Recall We are sending this alert because your patients may have filled a prescription for Montelukast Sodium 10mg Tablets. The product is labeled as Montelukast Sodium Tablets USP 10mg, but may […]
Read more
Hydrochlorothiazide Recall
August 30, 2018 / by Health Plan / Alerts, Pharmacy Announcements
Date: August 30, 2018 To: Health Plan of San Joaquin (HPSJ) Pharmacies and PCPs From: HPSJ Pharmacy Department Subject: Hydrochlorothiazide Recall Business: Medi-Cal Hydrochlorothiazide Recall We are sending this alert because your patients may have filled a prescription for Hydrochlorothiazide 12.5mg Tablet. The product is labeled as Hydrochlorothiazide Tablet USP 12.5mg, but may contain Spironolactone […]
Read more
ProDUR Update: Additive Toxicity Alert Now Focused Only On CNS Depressants
July 31, 2018 / by Health Plan / Pharmacy Announcements
Learning Objectives: Describe the drug safety communications by the U.S. Food and Drug Administration (FDA) regarding the combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS). Review the changes to the additive toxicity (AT) prospective drug utilization review (DUR) alert. Summarize best practices for responsible prescribing of […]
Read more
Drug Safety Communication: Adverse Effects from Fluoroquinolone Antibiotics
July 31, 2018 / by Health Plan / Pharmacy Announcements
Fluoroquinolone antibiotics are approved to treat certain serious bacterial infections and work by killing or stopping the growth of bacteria that can cause illness. On July 10, 2018, the U.S. Food and Drug Administration (FDA) announced it is strengthening the current warnings in the prescribing information for fluoroquinolone antibiotics. The new label changes will add […]
Read more
REMINDER: HPSJ members cannot be charged for medications
May 29, 2018 / by Health Plan / Alerts, Pharmacy Announcements
Date: May 29, 2018 To: HPSJ Network Pharmacies From: HPSJ Pharmacy Department Subject: REMINDER: HPSJ members cannot be charged for medications Business: Medi-Cal This is a reminder that both the Knox Keene Health Care Service Plan Act of 1975 (H&S §1379, §1385) and California Code of Regulations (28 CCR §1300.67.8) mandate that all providers who […]
Read more